Lexeo Therapeutics, Inc.'s total assets for Q3 2025 were $143.84M, a decrease of -18.30% from the previous quarter. LXEO total liabilities were $23.01M for the fiscal quarter, a -39.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.